Number of eligible individuals: CDEC mentioned the uncertainty in the number of patients with reasonably intense to intense hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical professionals consulted by CADTH indicated that some sufferers who're categorized as possessing moderate or average disorder could have a intense bleeding … Read More